Clinical Trial Update: Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating paricalcitol with fluorouracil and radiation therapy in patients with rectal cancer, including mucinous adenocarcinoma of the rectum. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucinous Adenocarcinoma of the Rectum
• Rectal Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Paricalcitol (paricalcitol)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Mucinous Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer | Phase 1 | Status: TERMINATED